Rx for Biotech cover art

Rx for Biotech

Rx for Biotech

Written by: Podcast Host Chris Leidli
Listen for free

About this listen

 The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the healthcare ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts who are developing advanced therapies and AI-powered health technologies including physicians, healthcare providers, patient advocates, and technology leaders. To learn more about Advanced Therapies, visit our Knowledge Base: https://www.advancedtherapiesconnect.ai/knowledge-base To find a specialist at an advanced therapy treatment center, visit our Advanced Therapy AI-powered referral tool here: https://www.advancedtherapiesconnect.ai/ To learn more about Genoplex, please visit https://www.genoplex.aiAll rights reserved Economics
Episodes
  • A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy

    A New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy
    Jan 15 2026
    This episode is about hope, and about a different way of thinking about cancer treatment. My guest is Dr. Øystein Rekdal, CEO and co-founder of Lytix Biopharma. Øystein is a scientist and leader who has spent decades studying how the immune system works - and how it can be helped to recognize and fight cancer more effectively. Rather than focusing only on destroying tumors, Lytix is working on therapies designed to wake up the immune system and help it remember cancer as a threat. It’s an approach that aims not just to treat disease, but to support the body’s own ability to respond. This is a conversation for anyone who wants to better understand where cancer care is headed, and why there’s real reason for optimism.
    Show More Show Less
    34 mins
  • Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control

    Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control
    Nov 20 2025
    InflaRx CEO Dr. Niels Riedmann joins Rx for Biotech to discuss how the company is pioneering complement-directed therapies to control severe inflammation and autoimmune disease. We break down the science behind INF904, and why C5a is such a powerful immune driver, and how precision immunology is shaping the next wave of treatment innovation.
    Show More Show Less
    35 mins
  • How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases

    How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases
    Nov 11 2025
    In this episode of Rx for Biotech podcast, I speak with Philippe Chambon MD, PhD, CEO of EG 427, about how his company's HERMES technology platform could improve on the precision, durability and safety of gene therapy delivery. EG 427's lead candidate, EG110A, targets neurogenic bladder - a chronic condition linked to spinal cord injury, Parkinson's disease and multiple sclerosis - using a localized gene therapy designed to restore neuronal control with minimal side effects.
    Show More Show Less
    29 mins
No reviews yet